Krintafel (tafenoquine) — Highmark
radical cure (prevention of relapse) of Plasmodium vivax malaria
Initial criteria
- age ≥ 16 years
- Diagnosis of Plasmodium vivax malaria (ICD-10: B51.9)
- Krintafel will be used for treatment of malaria or radical cure
- Krintafel will be used in combination with chloroquine or hydroxychloroquine
Approval duration
7 days (one-time authorization)